Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction

Implantable cardioverter defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. This study aimed to identify risk factors associated with mortality within one-year following the ICD. The data from our hospital's electro...

Descripción completa

Detalles Bibliográficos
Autores principales: Çinier, Göksel, Hayıroğlu, Mert İlker, Çınar, Tufan, Pay, Levent, Yumurtaş, Ahmet Çağdaş, Tezen, Ozan, Eren, Semih, Kolak, Zeynep, Çetin, Tuğba, Özcan, Serhan, Türkkan, Ceyhan, Özbilgin, Nazmiye, Tekkeşin, Ahmet İlker, Alper, Ahmet Taha, Gürkan, Kadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039682/
https://www.ncbi.nlm.nih.gov/pubmed/35104458
http://dx.doi.org/10.1016/j.ihj.2022.01.003
Descripción
Sumario:Implantable cardioverter defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. This study aimed to identify risk factors associated with mortality within one-year following the ICD. The data from our hospital's electronic database system was extracted for patients who were implanted ICD secondary to HFrEF between 2009 and 2019. Overall, 1107 patients were included in the present analysis. Mortality rate at one-year following the device implantation was 4.7%. In multivariate analysis; age, atrial fibrillation, New York Heart Association classification >2, blood urea nitrogen, pro-brain natriuretic peptide and albumin independently predicted one year mortality.

Ejemplares similares